Related Experiment Video
Updated: May 24, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Cardio-renal syndrome type 2: epidemiology, pathophysiology, and treatment
Preeti Jois1, Alexandre Mebazaa
1Department of Emergency Medicine, University of Florida, Gainesville, FL 32610, USA. preetijois@ufl.edu
Abstract:
Cardiac and kidney disease are becoming increasingly more prevalent in the population, and may exist concurrently. One of the most important comorbidities in heart failure is renal dysfunction. The pathophysiology of cardio-renal syndromes is complicated, and has been divided into five categories. Cardio-Renal syndrome type 2 is described by chronic cardiac abnormalities resulting in impaired renal function. It is important to recognize this entity and to understand the pathophysiology underlying the cardiac and renal disorders to distinguish best treatment practices. The success in improved outcomes lies in optimization of heart failure therapies.
Related Concept Videos
Hypertension II: Pathophysiology
Heart Failure II: Pathophysiology
Acute Kidney Injury II: Pathophysiology
Nephrotic Syndrome II : Assessment and Medical Management
Chronic Kidney Disease II: Clinical Manifestations
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
